International CRO International CRO

Cromos pharma: international CRO

Cromos Pharma: International CRO

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Vast US capabilities combined with an in-depth regional expertise in Central and Eastern Europe, Central Asia and Türkiye.

Learn more
No Patients No Payment No Patients No Payment

No Patients
No Payment

No Patients
No Payment

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

A unique risk-sharing program
If we don’t recruit –
Sponsor doesn’t pay.

Learn more
Free Multicountry Feasibility Report Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your clinical trials.

Learn more
Debating the Role of Interchangeability in Biosimilar Development Debating the Role of Interchangeability in Biosimilar Development

Interchangeability in Biosimilar Development

Interchangeability in Biosimilar Development

Should All US Biosimilars Have an “Interchangeable” Designation?

Should All US Biosimilars Have an “Interchangeable” Designation?

Learn more
Clinical Research Focus 20th edition | Cromos Pharma Clinical Research Focus 20th edition | Cromos Pharma

Clinical research focus. 20th edition

Clinical research focus. 20th edition

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Clinical Research Focus featuring topical articles of interest to the clinical trial community.

Learn more

Clinical Trials
in the Czech Republic

Clinical Trials
in the Czech Republic

A Prominent Hub for Scientific Discovery and Cost Optimization

A Prominent Hub for Scientific Discovery and Cost Optimization

Learn more
Cromos Pharma: International CRO No Patients
No Payment
 Free Multicountry Feasibility Report Interchangeability in Biosimilar Development Clinical research focus. 20th edition Featured Venue
of the Month
Meet Cromos Pharma
Global Site Solutions Simmut Logo
October 6-8, 2023
Hollywood, FL, USA
Clinical Trials Nexus Conference
October 17-18, 2023
Philadelphia, PA, USA
ESMO Congress | Cromos Pharma
October 20-24, 2023
Madrid, Spain
CPHI 2023 | Cromos Pharma
October 24-26, 2023
Barcelona, Spain
SITC San Diego 2023 Logo
November 1-5, 2023
San Diego, CA, USA
Contact us

why cromos pharma

Cromos Pharma is a US based international contract research organization (CRO) delivering integrated clinical research solutions that accelerate drug development.

Icon, clinical trials in central & easter europe
350 clinical trials conducted in 70+ indications
Icon, clinical trials in central & easter europe
120,000+ patients enrolled across 3,500 trial sites
Icon, clinical trials in central & easter europe
20+ operating countries with in-depth local expertise
Learn more

What we do

Icon, clinical trials in central & easter europe
Patient recruitment
Patient recruitment
  • Promotional and educational materials
  • DTC outreach
  • Investigator’s materials
  • Booster visits
  • Referral sites
  • Commitment to patients
  • Patient’s materials
Icon, clinical trials in central & easter europe
Clinical Research Services
Clinical Research Services
  • Capability and Feasibility Assessment
  • Project Management
  • Monitoring Services
Icon, clinical trials in central & easter europe
Regulatory
Services
Regulatory Services
  • Compilation of initial documents for RA and ECs/IRBs
  • Review of IC documentation
  • Obtaining of trial subjects’ insurance
  • Secure import/export licenses
  • Regional regulatory consultation
  • Regulatory strategy and clinical development planning
  • Submissions to Regulatory Agencies
icon - eu legal services
EU legal representation
EU legal representation
  • Your clinical gateway to Europe
  • Legal representation in EU/EEA
  • QP Statement obtainment
  • Cost-effective and time-saving services
Icon, clinical trials in central & easter europe
Medical
Writing
Medical Writing
  • Study concepts and outlines
  • Clinical study protocols and amendments
  • SAP for inclusion into protocol
  • Investigator Brochures
  • Investigational Medicinal Product Dossiers
  • Patient Informed Consent Forms
  • Clinical Study Reports
  • Executive summaries for efficacy or safety, ISS, ISE
  • Reviews of clinical and nonclinical data
  • Patient narratives, SAE narratives
  • Abstracts, posters, and journal articles
Icon, clinical trials in central & easter europe
Biostatistics
and data
management
Data Management
  • CRF development/validation
  • Customized database design/validation
  • Data entry screen design/validation
  • Double data entry
  • Programming under SAS
  • Data validation
  • Data listings
  • Convenient data format for the client
  • Data transfers
  • Data coding
Icon, clinical trials in central & easter europe
CTM
Logitics
CTM Logitics
  • Full Scope of Clinical Trial Logistics Services
  • Controlled access to storage areas
  • 24/7 receipt of IMP and CTM
  • Patented warehouse database program
  • General liability and property insurances
  • Compliance with ISO 9001:2015 & GDP
Icon, clinical trials in central & easter europe
PV
Support
PV Support
  • Therapeutic, technical, and operational excellence
  • Tailored and cost-effective safety solutions
  • Flexible outsourcing of safety functions
  • A team of QPPVs for registered products in EU
  • Updated country-specific regulatory requirements
  • Robust quality system
  • Pharmacovigilance consultancy
Icon, clinical trials in central & easter europe
Independent
Audits
Independent Audits
  • Clinical site GCP audits
  • Documentary Trial Master File audits
  • System Vendor Audits
  • Regulatory Inspection and Sponsor’s audit readiness check

No patients No payment

We are the only CRO that offers a unique risk sharing program, “No Patients – No Payment”, which means that when we don’t recruit, you don’t pay.

Learn more
1. Пилот, разборы, ответы и лайвы

No patients No payment

insights

News

Free Feasibility, Free Feasibility Report, Multicountry Free Feasibility Report
Cromos Pharma’s Free Multicountry Feasibility Report
We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your ongoing or upcoming clinical trial. You will get: Competitive trials landscape Review of local standards of care Historical recruitment analysis Regulatory requirements and timelines Realistic recruitment projections. The accuracy of Cromos Pharma’s Multicountry Report is backed by its proprietary “No Patients – No Payment” risk sharing model where you only pay if we deliver on our...
Read more
Cancer research challenges in Ukraine | Cromos Pharma
Cancer research challenges in Ukraine
In this article featured in Nature Journal, Vlad Bogin, MD, FACP, CEO of Cromos Pharma, offers insights into the prevailing challenges of conducting cancer research in...
Read more
Happy Labor Day from Cromos Pharma Team
Happy Labor Day 2023
On this special day, we celebrate the hard work and dedication of workers everywhere. It’s a time to relax, unwind, and enjoy the fruits of your labor.   From Cromos Pharma, we wish you a delightful Labor Day filled with relaxation, joy, and quality time with loved ones.   May this day rejuvenate you for the challenges and triumphs that lie ahead. Happy Labor...
Read more
Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer.
Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer
Cromos Pharma is thrilled to announce the commencement of a pivotal trial, focused on the investigation of OT-101, a collaborative effort between Oncotelic  Therapeutics and Sapu Bioscience, in individuals suffering from advanced and unresectable or metastatic pancreatic cancer. With this ambitious multicountry endeavor, Cromos Pharma’s aspiration is to deliver a long-awaited enhancement in survival outcomes for patients afflicted by this devastating illness.  Please read a press release here...
Read more
Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos
Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos
In today’s fast-moving world, visual information holds a unique power to simplify complex ideas and connect deeply. This becomes especially important when communicating with patients who need to navigate the intricate world of clinical trials. Each trial comes with its own complexities, and we need a way to present them in an easily understandable manner. This is where Cromos Pharma’s Audiovisual Department steps in as a valuable partner. Our skilled medical writers can turn even...
Read more
Hemochromatosis screening and awareness month | Clinical Trials
Hemochromatosis Screening And Awareness Month
Hemochromatosis: the Silent Iron Overload Disorder Hemochromatosis, a hereditary disorder characterized by excessive iron absorption and accumulation in the body, often goes undiagnosed or misdiagnosed due to its subtle symptoms. By understanding hemochromatosis, individuals can recognize the warning signs and seek appropriate medical attention, potentially preventing serious complications associated with iron overload. Screening for Hemochromatosis: Early detection of hemochromatosis is...
Read more

Events

Meet Vlad Bogin at the ESMO 2023 Congress | Cromos Pharma
Meet Vlad Bogin at the ESMO 2023 Congress
Join us in the beautiful city of Madrid, Spain, from October 20-24, 2023, as Cromos Pharma’s CEO, Vlad Bogin, MD, FACP, takes the stage at the prestigious ESMO Congress 2023! The ESMO Congress is the global epicenter of oncology, uniting clinicians, researchers, patient advocates, and healthcare industry leaders from every corner of the world. This is where groundbreaking discoveries happen, and we’re thrilled to be a part of it. ESMO 2023 promises an electrifying atmosphere...
Read more
Cromos Pharma’s CEO to present at the 18th BioPharma Clinical Trials Nexus Conference, which is set to take place October 17-18, 2023 in Philadelphia, USA.
Meet Cromos Pharma at the 18th Biopharma Clinical Trials Nexus Conference
Cromos Pharma’s CEO to present at the 18th BioPharma Clinical Trials Nexus Conference, which is set to take place October 17-18, 2023 in Philadelphia, USA. Cromos Pharma’s CEO Vlad Bogin, MD, FACP will be participating as a moderator in the panel discussion “Empowering and Advocating for patients in Clinical Trials”. Dr. Bogin is eager to connect with potential partners and clients to gain insights into their clinical development initiatives. You can reach out directly to us...
Read more
Meet Cromos Pharma at the Global Site Solutions Summit 2023
Meet Cromos Pharma at the Global Site Solutions Summit 2023!
We are delighted to announce that our Chief Operating Officer, Stephanie Finnegan, will be participating in the upcoming Global Site Solutions Summit, scheduled for October 6-8 in Hollywood, Florida. The Summit serves as a unique gathering point where site professionals, sponsors, CRO executives, and regulators converge to exchange best practices, foster innovative ideas, and cultivate strategic partnerships through interactive sessions, workshops, and focus groups. Stephanie will be readily...
Read more
Meet Cromos Pharma at the Clinical Operations in Oncology Trials East Coast 2023
Meet Cromos Pharma at the Clinical Operations in Oncology Trials East Coast 2023!
Cromos Pharma will be participating in the Clinical Operations in Oncology Trials East Coast, which is set to take place July 11-12, 2023 in Boston, MA. Cromos Pharma’s CEO Vlad Bogin, MD, FACP is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. Bringing together clinical operations experts from oncology pharma and biotech sponsor...
Read more
Nexus 2023, BioPharma Nexus
Cromos Pharma’s CEO Participated as a Speaker in the BioPharma Nexus Conference
Cromos Pharma’s CEO, Vlad Bogin, took part in the 17th BioPharma Nexus Conference. He participated as a speaker in the panel discussion “How to put Patients in the Heart of Clinical Trials & Daily Practice?” “Patient centricity is a critical topic in today’s clinical research,” opined Dr. Bogin. I truly enjoyed the discussion with a very knowledgeable panel of biopharma professionals”. We were excited to participate in this European event and look forward to the opportunity to take part...
Read more
Nexus Conference, clinical trials Nexus
Meet Cromos Pharma at the Clinical Trials Nexus Conference!
Cromos Pharma will be participating in the Clinical Trials Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam.  Cromos Pharma’s CEO Vlad Bogin, MD, FACP is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. Clinical Trials Nexus is a conference that brings together key decision-makers and senior clinical trials...
Read more

Publications

Debating the Role of Interchangeability in Biosimilar Development
Debating the Role of Interchangeability in Biosimilar Development
Should All US Biosimilars Have an “Interchangeable” Designation? Introduction: The world of biotechnology and pharmaceuticals has seen remarkable advancements in recent years, particularly in the development of biosimilars. Biosimilars, biologic drugs that are highly similar to already-approved reference biologics, have become a pivotal part of modern medicine, offering cost-effective alternatives to expensive originator biologics. However, one question continues to spark debate...
Read more
Clinical Research Focus 20th Edition September | Cromos Pharma
Clinical Research Focus. 20th Edition
After Receiving First GMO Clinical Trial Approval in Georgia, Cromos Pharma Reflects on Complex International Regulatory Landscape for GMO Research Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial in Georgia. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a comprehensive reflection of the intricate regulatory landscape governing GMO...
Read more
EMA Releases a Reflection Paper on the Role of AI in Drug Development
EMA Releases a Reflection Paper on the Role of AI in Drug Development
The European Medicines Agency (EMA) has released a reflection paper outlining its thoughts on integrating artificial intelligence (AI) in supporting the progression, oversight, and utilization of human and veterinary medicines. This document covers AI’s application from drug discovery to post-authorization. Part of the HMA-EMA Big Data Steering Group’s efforts, this paper is a collaborative endeavor involving EMA’s Committee for Medicinal Products for Human Use (CHMP) and...
Read more
Regulatory Landscapes of GMO Research Programs | Cromos Pharma
Cromos Pharma Contemplates Complex International GMO Research Program Regulations
Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a comprehensive reflection of the intricate regulatory landscape governing GMO trials in the US and EU. Initiating the first GMO clinical trial in Georgia presented a notable challenge Absence of prior GMO studies conducted in Georgia...
Read more
Decentralized Clinical Trials | Cromos Pharma
Decentralized Clinical Trials: Balancing the Promise and Pitfalls in Cost, Recruitment, and Patient Satisfaction
Decentralized clinical trials (DCTs) have emerged as a transformative solution in clinical research, leveraging remote technologies to streamline processes, boost patient satisfaction, and expedite recruitment. However, the potential pitfalls of increased costs and compromised recruitment and patient satisfaction warrant careful consideration by biotech professionals. This synthesis delves into the complex landscape of DCTs, addressing both their promise and the challenges they present. The...
Read more
Clinical research focus 19th edition
Clinical Research Focus. 19th Edition
Addressing the Underrepresentation of Older Adults in Cancer Clinical Trials: Advancing Inclusion for Improved Care The underrepresentation of older patients in cancer clinical trials poses a significant concern as it limits the generalizability of trial results to the broader population, particularly older adults who are affected by cancer more frequently. Various factors contribute to the exclusion of older participants, including age-related eligibility criteria, preexisting conditions...
Read more

Videos

1. Пилот, разборы, ответы и лайвы
Cromos Pharma’s Free Multicountry Feasibility Report
1. Пилот, разборы, ответы и лайвы
Understanding ARR, RRR and NNT
1. Пилот, разборы, ответы и лайвы
The Invaluable Role of Explainer Videos
1. Пилот, разборы, ответы и лайвы
The Czech Republic Country Profile
1. Пилот, разборы, ответы и лайвы
Poland Country Profile
1. Пилот, разборы, ответы и лайвы
The Baltic States Countries’ Profile